SAVING LIVES THROUGH BETTER SCIENCE™
Kirkstall Ltd. is a biotechnology company, established in 2006 to satisfy the overwhelming need for more human relevant science, brought about by the failures of traditional in vitro research and animal research models.
Building on the revolutionary research at the University of Pisa, Kirkstall spent five years working with bio-engineering specialists and academic and industry researchers to develop a family of products that meet real customer needs.
By forging partnerships with leading research laboratories, Kirkstall has validated the benefits of the Quasi Vivo® system in a wide variety of applications whilst also developing a network of technical specialists to provide valuable support to our customers worldwide.
Our vision of the future involves the further development and adoption of computer and microtechnology which will enable the academic and industry research community to save more human lives through a more effective application of human relevant science.
In particular we will build practical, easy to use “organ-on-a-chip” models to replace the use of animals in many areas of medical research.
Developing and nurturing close working relationships with our customers allows us to discover and develop the most innovative and effective technologies which provide the most practical and cost effective solutions to the challenges researchers face, with a particular focus on developing products for applications in drug development and safety testing.
By delivering wider benefits to the research community and providing tools and equipment that precisely control the environment for the culture of human cells, researchers will significantly improve the robustness and repeatability of biological research.
Creating innovative technologies relies upon complimentary relationships and continual research. Kirstall currently collaborates with, or supports research, in several leading Universities across Europe including:
- University of Pisa, Italy
- University of Sheffield, UK
- Newcastle University, UK
- University of Nottingham, UK
- University of Montpellier, France
- Queen Mary University of London, UK
- University of Leeds, UK
- Manchester Metropolitan University, UK
Our commitment to replacing animal research within scientific research also means that we work closely with a number of charitable organisations:
Established in 2006, Kirkstall won the Venturefest Investment competition in 2007 and went onto secure further seed funding from the South Yorkshire Investment Fund.
In 2008 Kirkstall succeeded in attracting a GRD grant and secured further investment from the Viking Fund and Angel Investors, with substantial more recent further investment made by Braveheart Investment Group.
Kirkstall offers great opportunities for investors, please contact us for further information.
ADVANCES IN CELL & TISSUE CULTURE CAMBRIDGE
Kirkstall Ltd. is the founder and organiser of the ACTC Conferences, which has a strong focus on new and novel in vitro research.
Our next event will be hosted at the University of Cambridge on the 4th and 5th December 2018, with the following sessions; Advanced In Vitro Liver Models, Developments in In Vitro Cancer Research, More Human Relevant ALI Models, Exploring New Trends in Stem Cell Research and Building Better Blood Brain Barrier Models.
SIGN UP FOR OUR ENEWSLETTER
We will only ever send you emails related to Kirkstall Ltd. and will not share your information with any third parties. By clicking submit below, you agree that we may process your information in accordance with these terms.
Address: Kirkstall Ltd
3 Aspen Court
Centurion Business Park
Phone: + 44 (0) 1709 361 241
Business Hours: Monday to Friday 8:00am-5:00pm (GMT)